1. Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands. Issue 1 (December 2016) Authors: Miquel-Cases, Anna; Steuten, Lotte; Rigter, Lisanne; van Harten, Wim Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of a web-based tool for the assessment of health and economic outcomes of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Issue 3 (December 2015) Authors: Boehler, Christian; de Graaf, Gimon; Steuten, Lotte; Yang, Yaling; Abadie, Fabienne Journal: BMC medical informatics and decision making Issue: Volume 15:Issue 3(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Economic value of procalcitonin guidance. Issue 9 (September 2016) Authors: Steuten, Lotte; Mantjes, Gertjan Journal: Lancet infectious diseases Issue: Volume 16:Issue 9(2016:Sep.) Page Start: 1000 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective. (September 2015) Authors: Kip, Michelle; Monteban, Helma; Steuten, Lotte Journal: Journal of comparative effectiveness research Issue: Volume 4:Number 5(2015) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP256 Recognising The Broader Value Of Vaccines In Health Technology Assessment: Worth A Shot?. (December 2021) Authors: Neri, Margherita; Brassel, Simon; Steuten, Lotte Journal: International journal of technology assessment in health care Issue: Volume 37(2021)Supplement 1 Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PP259 Invisible Resilience: The Value Of Medical Technology In Reducing Population And Health Systems' Vulnerability To COVID-19. (December 2021) Authors: Steuten, Lotte; Zamora, Bernarda; Lothgren, Mickael; Bruce, Andrew; Towse, Adrian Journal: International journal of technology assessment in health care Issue: Volume 37(2021)Supplement 1 Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Realising the broader value of vaccines in the UK. (August 2021) Authors: Brassel, Simon; Neri, Margherita; O'Neill, Phill; Steuten, Lotte Journal: Vaccine Issue: Volume 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries. Issue 1 (December 2015) Authors: Mewes, Janne; Steuten, Lotte; Groeneveld, Iris; de Boer, Angela; Frings-Dresen, Monique; IJzerman, Maarten; van Harten, Wim Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Working towards a sustainable, healthy market for vaccines: A framework to support evidence-based policymaking. Issue 29 (23rd June 2022) Authors: Rodes-Sanchez, Marina; Spencer, Julia; Tantri, Anupama; Mitrovich, Rachel; Rachev, Boris; Sharma, Isha; Towse, Adrian; Steuten, Lotte Journal: Vaccine Issue: Volume 40:Issue 29(2022) Page Start: 3919 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗